Brenda Banwell
Overview
Explore the profile of Brenda Banwell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
235
Citations
10955
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Espinoza D, Zrzavy T, Breville G, Thebault S, Marefi A, Mexhitaj I, et al.
bioRxiv
. 2025 Mar;
PMID: 40060552
The cerebrospinal fluid (CSF) provides a unique glimpse into the central nervous system (CNS) compartment and offers insights into immune processes associated with both healthy immune surveillance as well as...
2.
Gombolay G, Johnson L, King R, Hebert M, Banwell B, Chitnis T, et al.
J Neurol Neurosurg Psychiatry
. 2025 Jan;
PMID: 39848676
Background: Limited data are available on the global rates of paediatric multiple sclerosis. Here, we report on the estimated worldwide prevalence of paediatric MS. Methods: We included paediatric prevalence data...
3.
Mar S, Valeriani M, Steinborn B, Schreiner T, Waubant E, Filippi M, et al.
J Neurol
. 2025 Jan;
272(2):137.
PMID: 39812825
Background: The presented study identified the appropriate ocrelizumab dosing regimen for patients with pediatric-onset multiple sclerosis (POMS). Methods: Patients with POMS aged 10-17 years were enrolled into cohort 1 (body...
4.
Mok N, Knox N, Zhu F, Arnold D, Bar-Or A, Bernstein C, et al.
Front Microbiol
. 2025 Jan;
15:1258978.
PMID: 39744394
Evidence suggests that the gut microbiome may play a role in multiple sclerosis (MS). However, the majority of the studies have focused on gut bacterial communities; none have examined the...
5.
Amezcua L, Rotstein D, Shirani A, Ciccarelli O, Ontaneda D, Magyari M, et al.
Lancet Neurol
. 2024 Sep;
23(10):1050-1062.
PMID: 39304244
The differential diagnosis of suspected multiple sclerosis has been developed using data from North America, northern Europe, and Australasia, with a focus on White populations. People from minority ethnic and...
6.
Hua L, Solomon A, Tenembaum S, Scalfari A, Rovira A, Rostasy K, et al.
JAMA Neurol
. 2024 Sep;
PMID: 39283621
Importance: While the typical onset of multiple sclerosis (MS) occurs in early adulthood, 2% to 10% of cases initially present prior to age 18 years, and approximately 5% after age...
7.
Fadda G, Banwell B, Elliott C, Fetco D, Arnold D, Waters P, et al.
Ann Neurol
. 2024 Sep;
96(6):1086-1091.
PMID: 39243229
Slowly expanding lesions (SELs) in adults with multiple sclerosis (MS) indicate a progressive pathological process. Whether SELs are present in pediatric-onset MS (POMS) or myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)...
8.
Geraldes R, Arrambide G, Banwell B, Rovira A, Cortese R, Lassmann H, et al.
Nat Rev Neurol
. 2024 Sep;
20(10):620-635.
PMID: 39227463
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an immune-mediated demyelinating disease that is challenging to differentiate from multiple sclerosis (MS), as the clinical phenotypes overlap, and people with MOGAD...
9.
Perlman J, Wetmore E, Lehner-Gulotta D, Banwell B, Bergqvist A, Coleman R, et al.
Sleep Med
. 2024 Aug;
122:213-220.
PMID: 39208520
Background: Sleep disturbance in MS is common and can significantly impair overall quality of life. The ketogenic diet (KD) associates with improved sleep quality in people living with epilepsy and...
10.
Mirza A, Zhu F, Knox N, Black L, Daly A, Bonner C, et al.
Commun Med (Lond)
. 2024 Jul;
4(1):148.
PMID: 39030379
Background: The interplay between diet and the gut microbiota in multiple sclerosis (MS) is poorly understood. We aimed to assess the interrelationship between diet, the gut microbiota, and MS. Methods:...